APP and Down syndrome: A similar approach of AON-mediated APP modification was studied for Down's syndrome where Chang et al. used an 18-mer PS-MOE AON to induce exon 17 skipping of the APP mRNA transcript to lower Aβ production [32] indicating the diversity as well as the reproducibility of this APP protein modification approach, both very crucial aspects in translational research.